【スタッフ紹介】清家 圭介

卒業年：２０１１年（平成２３年）

学位取得：２０２０年（令和２年）6月

略歴：

２００３年（平成１５年）　３月　愛媛県立松山東高等学校卒業
２００５年（平成１７年）　４月　岡山大学医学部医学科入学
２０１１年（平成２３年）　３月　岡山大学医学部医学科卒業
２０１１年（平成２３年）　４月　岡山市立市民病院　初期研修医
２０１３年（平成２５年）　４月　岡山市立市民病院　後期研修医　血液・腫瘍内科
２０１３年（平成２５年）　９月　亀田総合病院　血液・腫瘍内科  医員　                　　
２０１４年（平成２６年）　９月　岡山大学病院　血液・腫瘍内科　医員
２０１６年（平成２８年）　４月　岡山大学大学院医歯薬学総合研究科　病態制御科学　入学
２０１７年（平成２９年）　６月　岡山大学病院　輸血部　医員
２０２０年（令和　２年）　１月　米国ミシガン大学血液腫瘍内科, Dr. Reddy Pavan研究室, Postdoctoral fellow
２０２０年（令和　２年）　６月　岡山大学大学院医歯薬学総合研究科　病態制御科学　修了　
２０２２年（令和　４年）　10月　岡山大学院医歯薬学総合研究科　血液・腫瘍・呼吸器内科学　助教

資　格・免　許：　　認定内科医（日本内科学会）、血液専門医・指導医（日本血液学会）

賞　　　　　罰：　２０２２年（令和４年）５月　UJA論文賞

研究テーマ：GVHDとGVL、ミトコンドリアと免疫細胞

一言：「人を診る」を心がけています。

業績：

Seike K, Kiledal A, Fujiwara H, Henig I, Burgos da Silva M, van den Brink MRM, Hein R, Hoostal M, Liu C, Oravecz-Wilson K, Lauder E, Li L, Sun Y, Schmidt TM, Shah YM, Jenq RR, Dick G, Reddy P.
Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.
Immunity. 2023

Kambara Y, Asada N, Kondo K, Sumii Y, Fujiwara Y, Seike K, Sando Y, Saeki K, Nishimori H, Fujii K, Fujii N, Matsuoka K, Maeda Y.
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony-stimulating factor for severe hypoxemia provoked by high-dose granulocyte colony-stimulating factor administration.
Transfus Med. 2022

Sun Y, Dotson GA, Muir LA, Ronquist S, Oravecz-Wilson K, Peltier D, Seike K, Li L, Meixner W, Rajapakse I, Reddy P.
Rearrangement of T Cell genome architecture regulates GVHD.
iScience. 2022

Kumar R, Landry AP, Guha A, Vitvitsky V, Lee HJ, Seike K, Reddy P, Lyssiotis CA, Banerjee R.
A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H(2)S oxidation.
J Biol Chem. 2022

Abe M, Fujii N, Mizuhara K, Urata T, Sumii Y, Fujiwara Y, Seike K, Sando Y, Nakamura M, Fujii K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka K, Maeda Y.
Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report.
Leuk Res Rep. 2021

Fujiwara H*, Seike K*, Brooks MD, Mathew AV, Kovalenko I, Pal A, Lee HJ, Peltier D, Kim S, Liu C, Oravecz-Wilson K, Li L, Sun Y, Byun J, Maeda Y, Wicha MS, Saunders TL, Rehemtulla A, Lyssiotis CA, Pennathur S, Reddy P. * These authors contributed equally.
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.
Nat Immunol. 2021

Kuroi T, Fujii N, Ichimura K, Seike K, Yamamoto A, Kambara Y, Sugimoto S, Otani S, Saeki K, Fujiwara H, Nishiomori H, Oto T, Maeda Y.
Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation.
Int J Hematol. 2021

Fujii K, Fujii N, Kondo T, Mitsuhashi T, Nakamura M, Seike K, Sando Y, Kimura M, Matsuda M, Ikegawa S, Sugiura H, Otsuka F, Maeda Y.
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection.
Transfus Apher Sci. 2021

Mizuhara K, Fujii N, Meguri Y, Takahashi T, Aoe M, Nakamura M, Seike K, Sando Y, Fujii K, Abe M, Sumii Y, Urata T, Fujiwara Y, Saeki K, Asada N, Ennishi D, Nishimori H, Matsuoka K, Maeda Y.
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy.
Int J Hematol. 2020

Seike K, Fujii N, Asano N, Ohkuma S, Hirata Y, Fujii K, Sando Y, Nakamura M, Naito K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Tsubaki K, Otsuka F, Maeda Y.
Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
Transfusion. 2020

Watanabe H, Ohashi K, Nishii K, Seike K, Makimoto G, Hotta K, Maeda Y, Kiura K.
A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages.
Intern Med. 2019

Nakamura M, Fujii N, Shimizu K, Ikegawa S, Seike K, Inomata T, Sando Y, Fujii K, Nishimori H, Matsuoka K, Morimatsu H, Maeda Y.
Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation.
Int J Hematol. 2018

Fujisawa M, Seike K, Fukumoto K, Suehara Y, Fukaya M, Sugihara H, Takeuchi M, Matsue K.
oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.
Cancer Sci. 2014